Business Wire

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

ZURICH--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis ...
Yahoo Finance

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

Preparations underway to advance AP-101 into confirmatory Phase 3 clinical trial with initiation aimed for late 2026 ZURICH, March 19, 2026--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage ...
The Register-Guard

Brazil takes center stage at Hannover Messe 2026 with industrial innovation and sustainability focus

As the event’s partner country, Brazil reinforces its position as Latin America’s largest economy, backed by robust and vertically integrated industrial sector ...
IEEE

Threshold-Free Event Detection for Nonintrusive Load Monitoring Using Motif Difference Field Images and Convolutional Neural Networks

Abstract: Event detection is a critical process in non-intrusive load monitoring (NILM). Accurate detection enhances subsequent load identification and facilitates a prompt understanding of the system ...